
Trevor Smith - Chairman
Trevor is a retired company executive, an angel investor and independent consultant / director. His 29 years in the tobacco industry include 10 years in Europe, culminating as Regional (Europe) CEO for Rothmans International, and Area Director for British American Tobacco. Trevor is the Chair of ICE Angels.
Michael Blennerhassett 
Michael has been appointed as a member of the Advisory Board of Ice Angels, an angel investment group based in Auckland. Michael works as an independent financial consultant, but prior to this spent fourteen years as an investment banker with First NZ Capital/Credit Suisse and more recently undertook a two year assignment in New Zealand and the United Kingdom as an executive director of financial software company, FNZ Holdings Ltd.

Brian Casey
Brian has been appointed as a member of the Advisory Board of Ice Angels, an angel investment group based in Auckland. Brian has managerial experience in the construction materials sector, has been a director and shareholder in company providing independent professional services to commodity traders, director of DIY retail stores, held a managerial position heading up mergers and acquisitions role at JSE listed company, director of a coal exporting company, recently GM and CEO for oil companies, and is currently CEO of Longbay Petroleum Associates Ltd, an energy consulting company.
Paul Dyson
Paul has had profound experience in international technology companies operating from Australia, France, UK, USA, India and NZ. He has been CEO of two start-up technology companies (one, a medical technology company in England that listed in London for £100M (www.puricore.com) and the other, www.ultramotor.com an electric vehicle pioneer in India that is still privately held). As a consultant since 2001, Paul contributed at senior levels in more than a dozen other early-stage technology companies. In addition to running the business in the Middle East under contract for a large US-based medical device company, Paul is on the board of an Australian med-tech company and a trustee of a not-for-profit organisation in NZ.
Ken Erskine
Ken Erskine has extensive sales and marketing experience working with a spectrum of organisations ranging from local start up’s to global multinationals. With over fifteen years IT sales and marketing experience in NZ and Europe Ken has held senior management/leadership roles at Hewlett Packard and Compaq where he was also involved in the initial sponsorship of The ICEHOUSE.
Andy Hamilton
Andy has been CEO of The ICEHOUSE since its inception and was the founding Chair of Incubators New Zealand the industry group representing incubators in New Zealand. He is a Board member of ANZATEC – the Australian New Zealand Technology Forum based in Silicon Valley, a group who is tasked with creating a gateway for NZ and Australian technology companies to enter the US. Prior to joining the ICEHOUSE, Andy was CEO and Director of Inventure which was the VC arm of Fletcher Building.
John McDonald
John retired from a senior executive role at Fletcher Challenge in 2001 after a career of 37years. His experience covered a range of industries and countries involving management, finance, distribution, and marketing. John is also experienced in international finance, mergers, acquisitions and divestments and commercial negotiation. Today he is a company director and a trustee for a number of organisations and enjoying restoring native bush and wetlands on a 200 acre lake block in the Bay of Plenty.
Brent Ogilvie
Brent is co-founder of
Pacific Channel Limited, a life sciences and cleantech venture development and investment firm. Pacific Channel is a seed co-investment partner of the New Zealand Venture Investment Fund and Mr. Ogilvie is an accredited broker under New Zealand Trade and Enterprise’s Escalator Service. Through Pacific Channel's activities as a seed investor, Mr. Ogilvie also serves as Director and Founding CEO of
Androgenix Limited and Breathe Easy Limited; and is co-founder and Director of
Ecodiesel Limited,
SciTOX Limited and
Somnaceutics Limited. Pacific Channel also secures investment for client companies including Migco Pharmaceuticals and Living Cell Technologies (ASX:LCT). Mr. Ogilvie was previously NZ Consul and Trade Commissioner to New York.